Evidence map

ArticleFrontiers in pharmacology2023

Heterogeneous treatment effects of Cerebrolysin as an early add-on to reperfusion therapy:

Mikhail N Kalinin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38249342